宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688247 宣泰医药

已收盘 12-27 15:00:01

{"stockData":{"symbol":"688247","market":"SH","secType":"STK","nameCN":"宣泰医药","latestPrice":10.57,"timestamp":1735282801000,"preClose":10.42,"halted":0,"volume":2413208,"delay":0,"changeRate":0.0144,"floatShares":142000000,"shares":453000000,"eps":0.2418,"marketStatus":"已收盘","change":0.15,"latestTime":"12-27 15:00:01","open":10.5,"high":10.67,"low":10.38,"amount":25523700,"amplitude":0.0278,"askPrice":10.58,"askSize":48,"bidPrice":10.57,"bidSize":98,"shortable":0,"etf":0,"ttmEps":0.2418,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735522200000},"marketStatusCode":5,"adr":0,"adjPreClose":10.42,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735263000000,1735270200000],[1735275600000,1735282800000]],"highLimit":11.46,"lowLimit":9.38,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":453340000,"isCdr":false,"pbRate":3.87,"roa":"--","peRate":43.713813,"roe":"7.58%","epsLYR":0.13,"committee":0.746939,"marketValue":4792000000,"turnoverRate":0.017,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-12-30。","afterMarket":{"amount":0,"volume":0,"close":10.57,"buyVolume":0,"sellVolume":0,"time":1735284838975,"indexStatus":"已收盘 12-27 15:30:00","preClose":10.42},"floatMarketCap":1504000000},"requestUrl":"/m/hq/s/688247/tweets","defaultTab":"tweets","newsList":[{"id":"2494878403","title":"宣泰医药12月27日主力资金流出8万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2494878403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494878403?lang=zh_cn&edition=full","pubTime":"2024-12-27 15:20","pubTimestamp":1735284027,"startTime":"0","endTime":"0","summary":"12月27日, 宣泰医药股价涨1.44%，报收10.57元，成交金额2552万元，换手率1.70%，振幅2.78%，量比0.87。宣泰医药今日主力资金净流出8万元，连续3日净流出，上一交易日主力净流出71万元，今日环比减少88.73%。该股近5个交易日下跌5.46%，主力资金累计净流出926万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1744万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227153612ab9474c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227153612ab9474c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2493093786","title":"宣泰医药跌5% 主力净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2493093786","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493093786?lang=zh_cn&edition=full","pubTime":"2024-12-23 14:18","pubTimestamp":1734934687,"startTime":"0","endTime":"0","summary":"12月23日，宣泰医药股价大幅下跌，截至14点18分，宣泰医药下跌5.01%，报10.62元/股，成交3233万元，换手率2.10%，振幅5.46%。资金动向截止发稿，宣泰医药获得主力净流出610万元，其中超大单流出303万元，大单流出305万元。主营业务及业绩宣泰医药公司主营业务为仿制药的研发、生产和销售以及CRO服务。最新财报显示，今年三季报，宣泰医药实现营业收入3.63亿元，同比增长69.95%，净利润为9,257.30万元，同比增长110.00%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122314183595ead0a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122314183595ead0a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2492964450","title":"宣泰医药跌5% 主营增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2492964450","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492964450?lang=zh_cn&edition=full","pubTime":"2024-12-17 14:42","pubTimestamp":1734417767,"startTime":"0","endTime":"0","summary":"12月17日，宣泰医药股价大幅下跌，截至14点42分，宣泰医药下跌5.02%，报10.98元/股，成交5617万元，换手率3.52%。融资融券方面，宣泰医药12月13日获得融资净买入64万元，当日该股融资余额为8634万元，当较前一日增加0.75%，实现3连增。最新财报显示，今年三季报，宣泰医药实现营业收入3.63亿元，同比增长69.95%，净利润为9,257.30万元，同比增长110.00%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217144259ab7e5a9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217144259ab7e5a9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2491769340","title":"宣泰医药(688247.SH)：碳酸司维拉姆片、马昔腾坦片拟中选全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2491769340","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491769340?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:35","pubTimestamp":1734086140,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宣泰医药 发布公告，近日，公司参与了第十批国家组织药品集中带量采购的投标。根据国家组织药品联合采购办公室于2024年12月12日发布的《全国药品集中采购拟中选结果公示》文件显示，公司产品碳酸司维拉姆片、马昔腾坦片中选本次集中带量采购，泊沙康唑肠溶片、枸橼酸托法替布缓释片未中选本次集中带量采购。本次集中带量采购中选结果拟于2025年4月实施，具体执行日期以各地发布通知为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宣泰医药(688247.SH)：碳酸司维拉姆片、马昔腾坦片拟中选全国药品集中采购","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2491301590","title":"宣泰医药：碳酸司维拉姆片、马昔腾坦片拟中选全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2491301590","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491301590?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:35","pubTimestamp":1734086140,"startTime":"0","endTime":"0","summary":"根据国家组织药品联合采购办公室于2024年12月12日发布的《全国药品集中采购拟中选结果公示》文件显示，公司产品碳酸司维拉姆片、马昔腾坦片中选本次集中带量采购，泊沙康唑肠溶片、枸橼酸托法替布缓释片未中选本次集中带量采购。本次集中带量采购中选结果拟于2025年4月实施，具体执行日期以各地发布通知为准。中选产品的采购合同签订等后续事项以及带量采购后市场销售执行情况尚具有不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213183741a1ebb8bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213183741a1ebb8bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2491479553","title":"宣泰医药最新公告：公司产品参与国家组织药品集中带量采购结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2491479553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491479553?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:09","pubTimestamp":1734084596,"startTime":"0","endTime":"0","summary":"宣泰医药公告，公司参与了第十批国家组织药品集中带量采购的投标，产品碳酸司维拉姆片、马昔腾坦片中选，而泊沙康唑肠溶片、枸橼酸托法替布缓释片未中选。中选结果拟于2025年4月实施。中选产品碳酸司维拉姆片2024年前三季度销售收入约156.09万元，占公司营业收入的0.43%；马昔腾坦片2024年前三季度销售收入为29.12万元，占公司营业收入的0.08%。本次中选将有利于扩大中选产品的销售规模，提高市场占有率，提升公司品牌影响力。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300034742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2491334118","title":"宣泰医药大跌 资金净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2491334118","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491334118?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:30","pubTimestamp":1733967035,"startTime":"0","endTime":"0","summary":"12月12日，宣泰医药股价大幅下跌，截至09点30分，宣泰医药下跌5.13%，报12.03元/股，成交1744万元，换手率1.00%，振幅2.29%。资金动向截止发稿，宣泰医药获得主力净流出21万元，其中超大单流出28万元，大单流入8万元。主营业务及业绩宣泰医药公司主营业务为仿制药的研发、生产和销售以及CRO服务。最新财报显示，今年三季报，宣泰医药实现营业收入3.63亿元，同比增长69.95%，净利润为9,257.30万元，同比增长110.00%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121209305795e9129e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121209305795e9129e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2490836086","title":"12月11日宣泰医药现1笔大宗交易 机构净买入1253万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490836086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490836086?lang=zh_cn&edition=full","pubTime":"2024-12-11 17:20","pubTimestamp":1733908826,"startTime":"0","endTime":"0","summary":"证券之星消息，12月11日宣泰医药发生大宗交易，交易数据如下：大宗交易成交价格12.53元，相对当日收盘价折价1.18%，成交100万股，成交金额1253万元，买方营业部为机构专用，卖方营业部为国泰君安证券股份有限公司上海江苏路证券营业部。近三个月该股共发生4笔大宗交易，合计成交3.25万手，折价成交4笔。截至2024年12月11日收盘，宣泰医药报收于12.68元，上涨15.17%，换手率17.16%，成交量24.42万手，成交额3.08亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100029459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2490610008","title":"宣泰医药大涨 获主力加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490610008","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490610008?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:30","pubTimestamp":1733880601,"startTime":"0","endTime":"0","summary":"12月11日，宣泰医药股价大幅上涨，截至09点30分，宣泰医药上涨6.09%，报11.68元/股，成交568万元，换手率0.34%，振幅0.64%。资金动向截止发稿，宣泰医药获得主力净流入94万元，其中超大单流入206万元，大单流出111万元。融资融券方面，宣泰医药12月09日获得融资净买入238万元，当日该股融资余额为6607万元，当较前一日增加3.74%。最新财报显示，今年三季报，宣泰医药实现营业收入3.63亿元，同比增长69.95%，净利润为9,257.30万元，同比增长110.00%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121109303395e8cdac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121109303395e8cdac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2486801783","title":"宣泰医药股东拟减持不超1100万股 比例不超2.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486801783","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486801783?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:35","pubTimestamp":1732754100,"startTime":"0","endTime":"0","summary":"财中社11月28日电宣泰医药 发布持股5%以上股东减持股份计划公告。该股东计划因自身经营需要，拟通过集中竞价或大宗交易方式减持不超过1100万股，减持比例不超过2.4264%。减持的具体时间为2024年12月19日至2025年3月18日。此次减持计划中，栖和创业承诺在任意连续90日内，集中竞价交易减持总数不超过1%，大宗交易减持总数不超过2%。2024年前三季度，宣泰医药实现收入3.63亿元，归母净利润9257万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083701abe468f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083701abe468f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688193","688139","688566","600976","603538","688163","688161","688105","688373","688073","603439","603392","688212","603658","600079","688166","605177","603259","688382","688278","688062","600056","688356","688137","603367","600436","688506","688520","688198","603456","600998","600329","603233","603896","688176","688443","600511","600529","688177","688085","688221","688189","603707","688301","603301","688670","688046","603567","600488","600161","688575","688266","600420","600851","600721","600763","BK0185","688428","BK0096","688202","688687","688298","688336","688247","600351","603882","688767","688581","BK0070","600055","159938","688276","600276","600867","600739","688578","600771","600062","688690","688351","600521","600566","688192","BK0028","600285","688067","688117","600252","BK0188","600196","688050","688029","688235","603939","688626","688389","603309","601607","688488","603590","688656","688222","688091","600129","688617","600380","603858","688271","600200","688658","BK0239","688331","605199","603087","688076","600211","600085","600572","603108","688114","688180","600535","600422","600080","688315","603127","BK0012","600332","688321"],"gpt_icon":0},{"id":"2486582791","title":"11月27日上市公司减持汇总：宣泰医药等6股拟减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2486582791","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486582791?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:29","pubTimestamp":1732717740,"startTime":"0","endTime":"0","summary":"据统计，11月27日，盘后包括蓝箭电子、宣泰医药、永和智控、理工能科、昀冢科技、金力泰（维权）在内的6家A股上市公司披露减持情况。\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-27/doc-incxppfe3302623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2486972821","title":"宣泰医药最新公告：股东栖和创业拟减持不超过2.43%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486972821","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486972821?lang=zh_cn&edition=full","pubTime":"2024-11-27 21:20","pubTimestamp":1732713649,"startTime":"0","endTime":"0","summary":"宣泰医药公告称，公司持股5%以上股东南京市栖和创业投资合伙企业（有限合伙）（简称“栖和创业”）计划减持公司股份不超过1100万股，占公司总股本的比例不超过2.4264%。栖和创业目前持有公司股份3679.8万股，占公司总股本的8.1171%。减持计划的原因是股东自身经营需要。减持方式包括集中竞价和大宗交易，减持期间为公告披露之日起15个交易日后的3个月内。减持价格将按市场价格确定。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700037679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","161022","688247"],"gpt_icon":0},{"id":"2486182137","title":"宣泰医药(688247.SH)股东栖和创业拟减持不超2.43%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486182137","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486182137?lang=zh_cn&edition=full","pubTime":"2024-11-27 21:19","pubTimestamp":1732713569,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宣泰医药(688247.SH)公告，公司股东南京市栖和创业投资合伙企业(有限合伙)(简称“栖和创业”)计划根据市场情况拟通过集中竞价或大宗交易的方式减持其所持有的公司股份数量合计不超过1100万股，拟减持股份数量占公司总股本的比例不超过2.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","161022","688247"],"gpt_icon":0},{"id":"2486827976","title":"宣泰医药：栖和创业拟减持不超2.4264%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827976","media":"格隆汇资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827976?lang=zh_cn&edition=full","pubTime":"2024-11-27 21:16","pubTimestamp":1732713389,"startTime":"0","endTime":"0","summary":"格隆汇11月27日丨宣泰医药(688247.SH)公布，公司于2024年11月27日收到栖和创业出具的《关于上海宣泰医药科技股份有限公司股份减持计划的告知函》，因股东自身经营需要，栖和创业计划根据市场情况拟通过集中竞价或大宗交易的方式减持其所持有的公司股份数量合计不超过11,000,000股，拟减持股份数量占公司总股本的比例不超过2.4264%。其中以集中竞价方式减持的，减持期间为本公告披露之日起15个交易日后的3个月内；以大宗交易方式减持的，减持期间为本公告披露之日起15个交易日后的3个月内。减持价格按市场价格确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127211638a259ced5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127211638a259ced5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","161022","BK0239"],"gpt_icon":0},{"id":"2486719757","title":"宣泰医药：业绩说明会定于12月6日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2486719757","media":"每日经济新闻","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486719757?lang=zh_cn&edition=full","pubTime":"2024-11-25 15:40","pubTimestamp":1732520443,"startTime":"0","endTime":"0","summary":"每经AI快讯，宣泰医药 11月25日晚间发布公告称，公司2024年第三季度业绩说明会定于2024年12月6日(星期五)下午14:00-15:00，以上证路演中心网络互动的形式进行。2023年1至12月份，宣泰医药的营业收入构成为：医药制造业占比99.84%。宣泰医药的董事长是叶峻，男，52岁，学历背景为硕士；总经理是郭明洁，男，51岁，学历背景为硕士。截至发稿，宣泰医药市值为50亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125154201a253bb65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125154201a253bb65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2485285075","title":"宣泰医药跌5.76% 主力净流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2485285075","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485285075?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:13","pubTimestamp":1732255987,"startTime":"0","endTime":"0","summary":"11月22日，宣泰医药股价大幅下跌，截至14点13分，宣泰医药下跌5.76%，报10.80元/股，成交4297万元，换手率2.71%，振幅5.41%。资金动向截止发稿，宣泰医药获得主力净流出413万元，其中超大单流出140万元，大单流出272万元。最新财报显示，今年三季报，宣泰医药实现营业收入3.63亿元，同比增长69.95%，净利润为9,257.30万元，同比增长110.00%，基本每股收益为0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122141338abd68caf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122141338abd68caf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2483999938","title":"宣泰医药大跌5% 融资融券余额实现3连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2483999938","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483999938?lang=zh_cn&edition=full","pubTime":"2024-11-14 11:17","pubTimestamp":1731554278,"startTime":"0","endTime":"0","summary":"11月14日，宣泰医药股价大幅下跌，截至11点17分，宣泰医药下跌5.00%，报11.98元/股，成交7297万元，换手率4.22%。资金动向截止发稿，宣泰医药获得主力净流出1395万元，其中超大单流出1437万元，大单流入42万元。融资融券方面，宣泰医药11月12日获得融资净买入1119万元，当日该股融资余额为8705万元，当较前一日增加14.76%，实现3连增；该股融券余额为7万元，融券余量为0.62万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114111818abbf6312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114111818abbf6312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688247"],"gpt_icon":0},{"id":"2483702936","title":"宣泰医药11月13日获主力加仓2224万元 环比增加380.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483702936","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483702936?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:22","pubTimestamp":1731482535,"startTime":"0","endTime":"0","summary":"11月13日, 宣泰医药股价涨2.52%，报收12.61元，成交金额1.88亿元，换手率10.13%，振幅13.41%，量比1.39。宣泰医药今日主力资金净流入2224万元，连续4日净流入，上一交易日主力净流入463万元，今日环比增加380.35%。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为25.00%，平均涨幅为4.43%。该股近5个交易日上涨14.64%，主力资金累计净流入4057万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2669万元，其中净流入天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113154109abbc80ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113154109abbc80ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","BK0239"],"gpt_icon":0},{"id":"2483974870","title":"宣泰医药创1年新高 2024中国医药工业发展大会将启幕","url":"https://stock-news.laohu8.com/highlight/detail?id=2483974870","media":"智选洞察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483974870?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:30","pubTimestamp":1731461400,"startTime":"0","endTime":"0","summary":"11月13日，宣泰医药股价大幅上涨，截至09点30分，宣泰医药上涨6.99%，报13.16元/股，创近1年新高，成交462万元，换手率0.25%，振幅0.57%。11月16日至18日，2024中国医药工业发展大会也将在上海张江科学会堂举行。资金动向截止发稿，宣泰医药获得主力净流入1041万元，其中超大单流入418万元，大单流入623万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093802a231f62f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093802a231f62f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0185","BK0082","BK0188","600056","BK0239","BK0175","BK0010","688247","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-08-25","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路780号7层709室","stockEarnings":[{"period":"1week","weight":-0.0546},{"period":"1month","weight":-0.0391},{"period":"3month","weight":0.2394},{"period":"6month","weight":0.2892},{"period":"1year","weight":-0.0102},{"period":"ytd","weight":-0.03}],"companyName":"上海宣泰医药科技股份有限公司","boardCode":"AI0027","perCapita":"20372股","boardName":"医药制造业","registeredCapital":"45334万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0273},{"period":"3month","weight":0.1012},{"period":"6month","weight":0.1458},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.1429}],"survey":"　　上海宣泰医药科技股份有限公司的主营业务是高端仿制药的研发、生产和销售以及CRO服务。公司的主要产品是高端仿制药、CRO服务。公司先后获得“上海市专利工作试点企业”、“上海市‘专精特新’中小企业”、“第四届上海知识产权创新奖专利二等奖”等荣誉。","serverTime":1735348078182,"listedPrice":9.37,"stockholders":"6986人(较上一季度减少0.11%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宣泰医药,688247,宣泰医药股票,宣泰医药股票老虎,宣泰医药股票老虎国际,宣泰医药行情,宣泰医药股票行情,宣泰医药股价,宣泰医药股市,宣泰医药股票价格,宣泰医药股票交易,宣泰医药股票购买,宣泰医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}